5:16 PM ET
8-K
Shareholder Meeting
Moleculin Biotech Shareholder Meeting
Moleculin Biotech held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and ratified Grant Thornton LLP as the independent auditor. Stockholders also approved an amendment to the 2024 Equity Plan to increase the authorized shares by 3,861,894 and passed a non-binding advisory resolution on executive compensation.